Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Central Centrifugal Cicatricial Alopecia: Clinical Features, Trichoscopy, and Treatment Management
Description
The talk reviewed central centrifugal cicatricial alopecia (CCCA), a lymphocytic scarring alopecia that most often affects women of African descent but can occur more broadly. The speaker emphasized that early symptoms such as breakage, itching, tenderness, scaling, erythema, pustules, and pigment change should not be dismissed as simple dandruff or hair care issues. Trichoscopy is essential because active disease and signs of inflammation may be present even when the scalp looks relatively normal clinically, including in the posterior scalp. In a clinic study of 100 women, most were symptomatic, and persistent scaling and pustules were associated with worsening disease, often because topical anti-inflammatory treatment was not tolerated or not used, or because oils and other potentially harmful hair practices were continued. Treatment should be aggressive and individualized, using anti-inflammatory therapies such as topical and intralesional corticosteroids, doxycycline, anti-dandruff shampoos, minoxidil, and sometimes 5-alpha reductase inhibitors; newer options like oral JAK inhibitors, PRP, and low-level laser therapy were also discussed as emerging or adjunctive approaches. The speaker stressed that many patients can improve if treated early and consistently, but ongoing maintenance is needed. Hair care counseling is a major part of management: reduce traction and trauma, address braids, locks, wigs, relaxers, heat, and nighttime practices, and work with stylists when possible. Goals now include not only stopping symptoms and inflammation but also rescuing viable follicles, improving density, and setting realistic expectations about areas of permanent loss.
View moreConclusions
- CCCA is a progressive lymphocytic scarring alopecia that disproportionately affects women of African descent and can significantly impair quality of life.
- Early recognition of symptoms and subtle trichoscopic signs is crucial because clinical exam alone may miss active disease.
- Scalp scaling and pustules appear to mark more aggressive CCCA and are associated with worsening outcomes.
- Treating inflammation aggressively with topical or intralesional steroids, antibiotics such as doxycycline, and other anti-inflammatory agents can improve or stabilize many patients.
- Hair regrowth is possible when inflammation is controlled, but treatment often needs to be maintained long term and improvement is not immediate.
- Minimizing traction, heat, and other traumatic hair practices is an important part of management and likely improves treatment response.
- Patient education about hair care practices, styling alternatives, and realistic expectations is essential for better outcomes.
- Trichoscopy is valuable both for detecting disease activity beyond visible alopecia and for guiding biopsy and treatment decisions.
- Adjunctive options such as minoxidil, low-level laser therapy, PRP, JAK inhibitors, and surgical restoration may help selected patients, but evidence remains limited for some newer therapies.
- Without treatment, CCCA tends to progress, so early and ongoing intervention is emphasized as necessary to preserve remaining follicles.
- Khumalo NP et al. BJD 2007.
- Olsen EA et al. JAAD 2011.
- Yolanda Lenzy, personal communication, AAD 2016.
- Callender V, et al. Arch Dermatol 2012.
- Onamusi T, Larrondo J, McMichael AJ. Arch Dermatol Res. 2023 May 15. Epub ahead of print.
- Jackson T et al. Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendations. J Am Acad Dermatol. 2024 Jun;90(6):1182-1189.#10.1016/j.jaad.2023.12.073
- Cook MK, et al. Photodermatol Photoimmunol Photomed. 2023 Nov;39(6):673-675.
- Felix K, Portilla-maya N, Desouza B, Uwakwe L, McMichael A, JAMA Dermatol. 2020.
- Agu C, McMichael A. Central Centrifugal Cicatricial Alopecia. JAMA Dermatol. 2020;156(9):1036.#10.1001/jamadermatol.2020.1859